Table III.
Variable | Total number | Loss | Expression | P-value |
---|---|---|---|---|
Number | 179 | 50 | 123 | |
Age | ||||
≤48.5 | 71 | 39 | 32 | 0.005 |
>48.5 | 108 | 17 | 91 | |
Sex | ||||
Male | 108 | 31 | 77 | 0.739 |
Female | 71 | 25 | 46 | |
WHO grade | ||||
II | 38 | 21 | 17 | 0.507 |
III | 43 | 24 | 19 | |
IV | 98 | 71 | 27 | |
IDH | ||||
Mut | 73 | 34 | 39 | 0.003 |
WT | 106 | 22 | 84 | |
TERT | ||||
Mut | 97 | 11 | 86 | 0.001 |
WT | 82 | 45 | 37 | |
Ki-67 expression index | ||||
≤27.12 | 87 | 36 | 51 | 0.131 |
>27.12 | 91 | 20 | 71 | |
Recurrence (n) | ||||
Recurrence | 8 | 4 | 4 | 0.135 |
Non-recurrence | 171 | 52 | 119 |
ATRX, α thalassemia/mental retardation syndrome X-linked; WHO, world health organization; IDH, isocitrate dehydrogenase; TERT, telomerase reverse transcriptase; Ki-67, proliferation marker protein Ki-67.